Thibodaux Regional welcomes Neurologist to Medical Staff - The Times of Houma/Thibodaux
houmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from houmatimes.com Daily Mail and Mail on Sunday newspapers.
Wael Richeh, MD is recognized by Continental Who s Who
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Seelos Therapeutics Announces Year End 2020 Business Update
-Highlights of Continued Execution of Plans for Multiple Clinical Programs and Upcoming Catalysts
-Additions to the Clinical, Operational and Regulatory Teams
News provided by
Share this article
Share this article
NEW YORK, Jan. 6, 2021 /PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced its year end 2020 business update. This past year marked the most significant 12 months in Seelos Therapeutics history despite being an otherwise challenging year due to the COVID-19 pandemic. We completed our safety trial for the intranasal ketamine program and began opening centers for our pivotal trial for Acute Suicidal Ideation and Behavior in patients with major depressive disorder. The trehalose program s pivotal study in ALS was accepted into the HEALEY ALS Platform